Full Press Release Details
Data at AAN Demonstrate Biogen’s Leadership and Commitment to Innovation in MS.
BIIB
Data at AAN Demonstrate Biogen’s Leadership and Commitment to Innovation in MS
Key Takeaway: Data at AAN Demonstrate Biogen’s Leadership and Commitment to Innovation in MS
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis